Annually, we provide updates about the study, as well as related findings in the field. There are typically three presentations each year. One presentation is given by the study director and provides a general overview of how the study is progressing, and highlights of specific findings of note. The other two presentations provide more in-depth summaries of findings within a particular area of interest. These presentations were originally given as part of an in-person meeting, but since many participants and their study partners live a distance away from the Greater Baltimore/Washington area, we now make videos of the presentations and post them on our website. Examples of recent presentations are shown below.
Participant Forum 2022
BIOCARD Forum for Participants – 2022 (virtual)
The twelfth annual BIOCARD Participant Forum was held virtually. There are 3 presentations associated with this forum. They include: (1) an overview of the BIOCARD study and new initiatives for the coming years, (2) a discussion of physical activity and health, and (3) a discussion of blood biomarkers in Alzheimer’s disease.
Participant Forum 2021
BIOCARD Forum for Participants – 2021 (virtual)
The eleventh annual BIOCARD Participant Forum was held virtually, due the COVID-19 pandemic. There are 3 presentations associated with this forum. They include: (1) an overview of the BIOCARD study and new initiatives for the coming years, (2) a discussion of the association of vision loss with cognitive performance, and (3) a discussion of the findings from the Aducanumab clinical trial, including the controversy surrounding the approval of this drug for treatment of Alzheimer’s disease by the FDA.
Participant Forum 2020
BIOCARD Forum for Participants – 2020 (virtual)
The tenth annual BIOCARD Participant Forum was held virtually, due the COVID-19 pandemic. There are 3 presentations associated with this forum. They include: (1) an overview of the BIOCARD study and new initiatives for the coming years, (2) a discussion of the association of depressive symptoms with cognitive decline, and (3) a discussion of recent findings concerning changes in sleep and circadian rhythms among individuals with mild cognitive impairment.